Your browser doesn't support javascript.
loading
MiR-134, epigenetically silenced in gliomas, could mitigate the malignant phenotype by targeting KRAS.
Wang, Zhi-Liang; Zhang, Chuan-Bao; Wang, Zheng; Meng, Xiang-Qi; Liu, Xiao-Juan; Han, Bo; Duan, Chun-Bin; Cai, Jin-Quan; Hao, Zhong-Fei; Chen, Ming-Hui; Jiang, Tao; Li, Yong-Li; Jiang, Chuan-Lu; Wang, Hong-Jun.
Affiliation
  • Wang ZL; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
  • Zhang CB; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Wang Z; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
  • Meng XQ; Department of Neurosurgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilong Jiang Province, China.
  • Liu XJ; Hematological Department, Harbin Institute of Hematology and Oncology, Harbin, Heilong Jiang Province, China.
  • Han B; Department of Neurosurgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilong Jiang Province, China.
  • Duan CB; Department of Neurosurgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilong Jiang Province, China.
  • Cai JQ; Department of Neurosurgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilong Jiang Province, China.
  • Hao ZF; Department of Neurosurgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilong Jiang Province, China.
  • Chen MH; Department of Neurosurgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilong Jiang Province, China.
  • Jiang T; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
  • Li YL; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Jiang CL; Department of Neurosurgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilong Jiang Province, China.
  • Wang HJ; Department of Neurosurgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilong Jiang Province, China.
Carcinogenesis ; 39(3): 389-396, 2018 03 08.
Article in En | MEDLINE | ID: mdl-29432532
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Gene Expression Regulation, Neoplastic / Proto-Oncogene Proteins p21(ras) / MicroRNAs / Glioma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Carcinogenesis Year: 2018 Document type: Article Affiliation country: China Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Gene Expression Regulation, Neoplastic / Proto-Oncogene Proteins p21(ras) / MicroRNAs / Glioma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Carcinogenesis Year: 2018 Document type: Article Affiliation country: China Country of publication: Reino Unido